The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD
NCT00274222 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2006-01-10
Summary
This study was designed to evaluate the hypothesis that nebulized budesonide) might be an alternative to systemic corticosteroids (SC) in the treatment of patients with acute exacerbations of COPD (AECOPD).
Conditions
- COPD Acute Exacerbation
Sponsors & Collaborators
-
Inonu University
lead OTHER
Principal Investigators
-
HAKAN GUNEN, MD · INONU UNIVERSITY PULMONARY MEDICINE
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Completion
- 2005-10-31
More Related Trials
-
Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01551316 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Budesonide-Formoterol in Bronchiectasis
NCT00728715 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00739648 ·Status: COMPLETED ·Phase: PHASE2
-
Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)
NCT01253473 ·Status: COMPLETED ·Phase: PHASE4
-
Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
NCT00005880 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients
NCT02000609 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients
NCT00483743 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
NCT00476099 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT01013142 ·Status: COMPLETED ·Phase: PHASE1
-
Three Treatment of Chronic Obstructive Pulmonary Disease Patients
NCT04520230 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Corticosteroids to Treat Outpatients With Acute Exacerbations of COPD
NCT02330952 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02236182 ·Status: COMPLETED ·Phase: PHASE2
-
β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation
NCT01944033 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation
NCT01332097 ·Status: COMPLETED ·Phase: PHASE2
-
12-week Efficacy of Indacaterol
NCT01072448 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
NCT07133880 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00624286 ·Status: COMPLETED ·Phase: PHASE3
-
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
NCT00321893 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT03256695 ·Status: COMPLETED ·Phase: PHASE3
-
Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder
NCT01738087 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Optimal Inhaler Strategies During Acute Exacerbations of COPD (AECOPDs) Using Oscillometry
NCT06495047 ·Status: COMPLETED
-
Efficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACO
NCT03504527 ·Status: UNKNOWN ·Phase: NA
-
Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis
NCT00524095 ·Status: TERMINATED ·Phase: PHASE2
-
The Doses of Systemic Steroid in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
NCT01215825 ·Status: COMPLETED
-
COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers
NCT02291016 ·Status: COMPLETED ·Phase: NA